This part of our website is currently under development. Please check back with us later. Thanks for your patience and interest.
Further growth of Russian pharmaceutical market expected by its participants
28 April 2017
2017's first-quarter reports, with the newest from Big Pharma
Syndax Announces Expansion of Immuno-Oncology Collaboration Evaluating Entinostat in Combination with KEYTRUDA(R) (pembrolizumab) for the Treatment of Colorectal Cancer
27 April 2017
The top 9 overseas accounts in biopharma hold $133B in M&A firepower